Respiratory Function Assessment in Safety Pharmacology

Dennis J. Murphy1

1 GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania
Publication Name:  Current Protocols in Pharmacology
Unit Number:  Unit 10.9
DOI:  10.1002/0471141755.ph1009s22
Online Posting Date:  August, 2003
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

The known effects of drugs from a variety of pharmacological/therapeutic classes on the respiratory system, the life‐threatening consequences of respiratory dysfunction, and world‐wide regulatory safety guidelines all support the need for conducting respiratory evaluations in safety pharmacology. This unit provides an overview of the functional disorders of the respiratory system and presents the techniques and strategies considered to be most appropriate for detecting and characterizing drug‐induced respiratory disorders in safety pharmacology studies.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Functional Disorders of the Respiratory System
  • Techniques for Measuring Changes in Respiratory Function
  • Design of Respiratory Function Safety Studies
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Akoun, G.M., Milleron, B.J., Mayaund, C.M., and Francois, T.J. 1989. Natural history of drug‐induced pneumonitis. In Drug Induced Disorders, Vol. 3 (G.M. Akoun, and, P.J. White eds.) pp. 3‐9. Elsevier Scientific Publishers, New York.
   Amdur, M.O. and Mead, J. 1958. Mechanics of respiration in unanesthetized guinea pigs. Am. J. Physiol. 192:364‐368.
   American Thoracic Society Statement. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152:78‐121.
   American Thoracic Society Statement. 1991. Lung function testing: Selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 144:1202‐1218.
   Boggs, D.F. 1992. Comparative control of respiration. In Comparative Biology of the Normal Lung, Vol. 1 (R.A. Parent ed.) pp. 309‐350. CRC Press, Boca Raton, F.L.
   Borison, H.L. 1977. Central nervous system depressants: Control‐systems approach to respiratory depression. Pharm. Ther. 3:211‐226.
   Brown, L.K. and Miller, A. 1987. Full lung volumes: Functional residual capacity, residual volume and total lung capacity. In Pulmonary Function Tests: A Guide for the Student and House Officer (A. Miller, ed.) pp. 53‐58. Grune & Stratton, New York.
   Cherniack, N.S. 1988. Disorders in the control of breathing: Hyperventilation syndromes. In Textbook of Respiratory Medicine (J.F. Murray and J.A. Nadal, eds.) pp. 1861‐1866. W.B. Saunders, Philadelphia.
   Chitravanshi, V.C. and Sapru, H.N. 1999. Phrenic nerve responses to chemical stimulation of the subregions of ventral medullary respiratory neuronal group in the rat. Brain Res. 821:443‐460.
   Diamond, L. and O'Donnell, M. 1977. Pulmonary mechanics in normal rats. J. Appl. Physiol. 43:942‐948.
   Douglas, J.S., Dennis, M.W., Ridgeway, P., and Bouhuys, A. 1971. Airway dilation and constriction in spontaneously breathing guinea pigs. J. Pharm. Exp. Ther. 180:98‐109.
   Drazen, J.M. 1984. Physiological basis and interpretation of indices of pulmonary mechanics. Environ. Health Perspect. 56:3‐9.
   Drorbaugh, J.E. and Fenn, W.O. 1955. A barometric method for measuring ventilation in newborn infants. Pediatrics 16:81‐86.
   Eldridge, F.L. and Millhorn, D.E. 1981. Central regulation of respiration by endogenous neurotransmitters and neuromodulators. Annu. Rev. Physiol. 43:121‐135.
   Evans, R., Mullally, D.I., Wilson, R.W., Gergen, P.J., Rosenberg, H.M., Grauman, J.S., Chevarley, F.M., and Feinleib, M. 1987. National trends in the morbidy and mortality of asthma in the US. Chest 91:65‐74.
   Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G.L., Irvin, C.G., and Gelfand, E.W. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766‐775.
   Heymans, C. 1955. Action of drugs on carotid body and sinus. Pharm. Rev. 7:119‐142.
   Heymans, C. and Neil, E. 1958. The effects of drugs on chemoreceptors. In Reflexogenic Areas of the Cardiovascular System (C. Heymans and E. Neil, eds.) pp. 192‐199. Churchill, London.
   Jacky, J.P. 1980. Barometric measurement of tidal volume: Effects of pattern and nasal temperature. J. Appl. Physiol. 49:319‐325.
   Jorkasky, D. 1994. Phase I clinical trials: What is the minimum preclinical package necessary for initiating single‐dose studies in man?—A clinical pharmacologist's opinion. In The Timing of Toxicological Studies to Support Clinical Trials (C. Parkinson, N. McAuslane, C. Lumley, and, S. Walker, eds.) pp. 61‐65. Kluwer, Boston.
   Keats, A.S. 1985. The effects of drugs on respiration in man. Annu. Rev. Pharm. Toxicol. 25:41‐65.
   King, T.K.C. 1966. Measurement of functional residual capacity in the rat. J. Appl. Physiol. 21:233‐236.
   Kruger, J.J., Bain, T., and Patterson, J.L., Jr., 1961. Elevation gradient of intrathoracic pressure. J. Appl. Physiol. 16:465‐468.
   Lucke, J.N., Hall, G.M., and Lister, D. 1976. Porcine malignant hyperthermia I: Metabolic and physiologic changes. Br. J. Anesth. 48:297‐304.
   Mauderly, J.L. 1974. The influence of sex and age on the pulmonary function of the beagle dog. J. Gerontol. 29:282‐289.
   Mauderly, J.L. 1989. Effect of inhaled toxicants on pulmonary function. In Concepts in Inhalation Toxicology (R.O. McClellan, and, R.F. Henderson, eds.) pp. 347‐401. Hemisphere Publishing, New York.
   McCarthy, D.S. 1981. Airflow obstruction. In Pathophysiology of Respiration (M.H. Kryger, ed.) pp. 7‐42. John Wiley & Sons, New York.
   Milic‐Emili, J. 1982. Recent advances in clinical assessment of control of breathing. Lung 160:1‐17.
   Monro, A. and Mehta, D. 1996. Are single dose toxicology studies in animals adequate to support single doses of a new drug in humans? Clin. Pharm. Ther. 59:258‐264.
   Mueller, R.A., Lundberg, D.B.A., Breese, G.R., Hedner, J., Hedner, T., and Jonason, J. 1982. The neuropharmacology of respiratory control. Pharmacol. Rev. 34:255‐285.
   Murphy, D.J., Joran, M.E., and Renninger, J.E. 1993. Effects of adenosine agonists and antagonists on pulmonary ventilation in conscious rats. Gen. Pharm. 24:943‐954.
   Murphy, D.J., Joran, M.E., and Grando, J.C. 1994. Microcapnometry: A non‐invasive method for monitoring arterial CO2 tension in conscious rats. Toxicol. Methods 4:177‐187.
   Murphy, D.J., Joran, M.E., and Grando, J.C. 1995. A non‐invasive method for distinguishing central from peripheral nervous system effects of respiratory depressant drugs in conscious rats. Gen. Pharm. 26:569‐575.
   Murphy, D.J., Renninger, J.P., and Gossett, K.A., 1998. A novel method for chronic measurement of pleural pressure in conscious rats. J. Pharm. Toxicol. Methods 39:137‐141.
   Murphy, D.J., Renninger, J.P., and Coatney, R.W. 2001. A novel method for chronic measurement of respiratory function in the conscious monkey. J. Pharm. Toxicol. Methods 46:13‐20.
   Nuzzo, P.F. and Anton, W.R. 1986. Practical applications of capnography. Res. Ther. 16:12‐17.
   O'Neil, J.J. and Raub, J.A. 1984. Pulmonary function testing in small laboratory animals. Environ. Health Perspect. 56:11‐22.
   Palecek, F. 1969. Measurement of ventilatory mechanics in the rat. J. Appl. Physiol. 27:149‐156.
   Pennock, B.E., Cox, C.P., Rogers, R.M., Cain, W.A., and Wells, J.H. 1979. A noninvasive technique for measurement of changes in specific airway resistance. J. Appl. Physiol. 46:39‐406.
   Phillipson, E.A. 1988. Disorders in the control of breathing: Hypoventilation syndromes. In Textbook of Respiratory Medicine (J.F. Murray and J.A. Nadal eds.) pp. 1831‐1840. W.B. Saunders Co., Philadelphia
   Raine, J.M., Palazzo, M.G., Kerr, J.H., and Sleight, P. 1981. Near fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. Br. Med. J. 282:548‐549.
   Rochester, D.F. and Arora, N.S. 1983. Respiratory muscle failure. Med. Clin. North Am. 67:573‐597.
   Rosenow, E.C., Myers, J.L., Swensen, S.J., and Pisani, R.J. 1992. Drug induced pulmonary disease: An update. Chest 102:239‐250.
   Sant'Ambrogio, G. 1987. Nervous receptors of the tracheobronchial tree. Annu. Rev. Physiol. 49:611‐627.
   Smolders, F.D.J., Folgering, H.T., and Bernards, J.A. 1975. Ventilation estimated from efferent phrenic nerve activity in the paralyzed cat. Pflugers Arch. 359:157‐169.
   Syabbalo, N. 1998. Assessment of respiratory muscle function and strength. Postgrad. Med. J. 74:208‐215.
   Tattersfield, A.E. and Harrison, R.N. 1983. Effect of β‐blocker therapy on airway function. Drugs 25:227‐231.
   Trenchard, D., Gardner, D., and Guz, A. 1972. Role of pulmonary vagal afferent nerve fibers in the development of rapid shallow breathing in lung inflammation. Clin. Sci. 42:251‐263.
   Warren, C.P.W. 1981. Lung restriction. In Pathophysiology of Respiration (H. Kryger, ed.) pp. 43‐69. John Wiley & Sons, New York.
   Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., and Badr, S. 1993. The occurrence of sleep‐disordered breathing among middle‐aged adults. New Engl. J. Med. 328:1230‐1235.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library